Metabolic Solutions Development Company

14 articles about Metabolic Solutions Development Company

• Metabolic Solutions Development Company Appoints Robert L. Zerbe, MD To Board Of Managers

  10/23/2014

• Metabolic Solutions Development Company Presents Phase 2a Clinical Trial Results at the 14th International Conference on Alzheimer's Drug Discovery

  9/9/2013

• Metabolic Solutions Development Company Announces Publication of Data Describing Potential for New Drugs to Maintain Pancreatic Beta-Cells in Treating Diabetes

  5/30/2013

• Metabolic Solutions Development Company Awarded Funding by The Michael J. Fox Foundation

  2/7/2013

• Metabolic Solutions Development Company Announces Publication of Phase 2b Data in Clinical Pharmacology & Therapeutics

  1/25/2013

• Metabolic Solutions Development Company Receives $1.1 Million National Institutes of Health (NIH) Grant to Further Investigate MSDC-0602 for the Treatment of Fatty Liver Disease

  10/7/2011

• Metabolic Solutions Development Company Presents New Brown Fat Research at the European Association for the Study of Diabetes

  9/13/2011

• Metabolic Solutions Development Company Reports Positive Top-Line Results From Phase 2a Study of its Second Compound to Treat Type 2 Diabetes

  9/9/2011

• Metabolic Solutions Development Company Raises Another $6.8 Million

  8/16/2011

• Metabolic Solutions Development Company Receives $773,000 From the Alzheimer's Drug Discovery Foundation to Fund Phase 2a Trial

  7/6/2011

• Metabolic Solutions Development Company to Present Recent Findings on the Therapeutic Potential of Increasing Brown Fat in the Treatment of Diabetes at Annual American Diabetes Association Conference

  6/21/2011

• Metabolic Solutions Development Company Launches Phase 2a Trial of Its Second Compound to Treat Type 2 Diabetes

  3/29/2011

• Metabolic Solutions Development Company Announces Preliminary Results from Phase IIa Clinical Trial

  5/14/2009

• Metabolic Solutions Raises $10 Million

  5/13/2009